Ask AI
ProCE Banner Activity

Transforming Care in Cutaneous Squamous Cell Carcinoma: Integrating Immunotherapy Into Patient Care

Podcast Episodes

In this podcast, Dr David Miller and Dr Vishal Patel discuss advances in the management of cutaneous squamous cell carcinoma (cSCC), exploring how neoadjuvant and adjuvant immunotherapy is transforming treatment paradigms and highlighting patient selection, toxicity management, and emerging strategies to improve patient care.

Released: November 03, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc

Disclosure

Primary Author

David M. Miller, MD, PhD, FAAD: consultant/advisor/speaker: Almirall, Bristol Myers Squibb, Checkpoint Therapeutics, EMD Serono, Merck, Regeneron, Sanofi Genzyme, Sun Pharma; researcher: Kartos Therapeutics, NeoImmune Tech, Inc, Project Data Sphere, Regeneron; other (stock options): Avstera Therapeutics.

Vishal Anil Patel, MD: consultant/advisor/speaker: Almirall, Regeneron, Replimune, Sun.